Table 1.
ID | Age | Gender1 | Cirrhosis in nontumorous tissue | Grade | Anti-HCV | HBsAg |
---|---|---|---|---|---|---|
F003 | NA2 | NA | NA | NA | NA | NA |
F004 | 67 | M | + | II | + | + |
F005 | 47 | M | − | II | − | + |
F006 | 70 | F | − | I | + | − |
F007 | NA | NA | NA | NA | NA | NA |
F008 | NA | M | NA | NA | NA | NA |
F009 | 56 | M | − | NA | NA | + |
F011 | NA | NA | NA | NA | NA | NA |
F012 | 39 | M | − | III | + | + |
F013 | 78 | M | + | II–III | − | + |
F014 | 42 | M | − | III | − | + |
F015 | NA | NA | NA | NA | NA | NA |
F017 | 70 | F | − | II | + | − |
F018 | 51 | M | − | II | − | + |
F019 | 20 | M | − | I–II | − | + |
F020 | NA | NA | NA | NA | NA | NA |
F021 | 45 | M | − | II | − | + |
F022 | 58 | M | + | I | + | − |
F023 | 43 | M | − | II | − | + |
F025 | 51 | M | − | II | + | − |
F028 | 35 | F | − | III | NA | + |
F029 | 49 | M | + | II | − | + |
F030 | 37 | M | − | II | − | + |
F032 | 50 | M | − | II | − | + |
F033 | 48 | M | − | III | + | + |
F034 | 44 | M | − | I–II | NA | + |
F035 | 49 | M | + | III–IV | − | + |
F036 | 62 | F | + | III | + | + |
F038 | 62 | M | + | II | + | + |
F039 | 69 | M | + | III | − | − |
F040 | 76 | M | − | III | − | + |
F042 | 40 | M | − | II | NA | + |
F043 | 59 | F | + | III | − | + |
F044 | NA | NA | NA | NA | NA | NA |
F045 | 63 | M | + | II | − | + |
F047 | 45 | M | + | II | − | + |
F048 | 68 | M | + | II | NA | + |
B115 | 45 | M | + | NA | − | + |
B169 | 53 | M | NA | NA | − | − |
D145 | 58 | M | NA | NA | + | NA |
M, male; F, female;
NA, data not avalable